`571-272-7822
`
`
`
`
`
`
`
`Paper 37
`Date: December 14, 2018
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`MYLAN PHARMACEUTICALS INC.,
`Petitioner,
`
`v.
`
`BRISTOL-MYERS SQUIBB COMPANY and PFIZER INC.,
`Patent Owners.
`
`
`
`Case IPR2018-00892
`Patent 9,326,945 B2
`
`
`
`
`
`Before SHERIDAN K. SNEDDEN and KRISTI L. R. SAWERT,
`Administrative Patent Judges.
`
`
`SNEDDEN, Administrative Patent Judge.
`
`
`ORDER
`Granting Petitioner’s Motion to Submit Supplemental Information
`37 C.F.R. § 42.123(a)
`
`
`
`I.
`
`IPR2018-00892
`Patent 9,326,945 B2
`
`INTRODUCTION
`Petitioner requested authorization to file a motion to submit
`supplemental information under 37 C.F.R. § 42.123(a) within one-month of
`our institution of trial. Paper 30. We authorized Petitioner to file the
`motion. Id. Petitioner filed a Motion to Submit Supplemental Information
`(Paper 32; “Mot.”) and Patent Owner filed an Opposition (Paper 36;
`“Opp.”).
`In its motion, Petitioner proposes to submit, as supplemental
`information, a corrected version of Rudnic containing the correct header
`pages. Mot. 1. Rudnic is cited by Petitioner in support of Grounds 2 and 4
`in the Petition as Exhibit 1010. Id. at 1–2. Petitioner explains that the
`substantive portion of Ex. 1010 is Chapter 10 of the third edition of the
`textbook Modern Pharmaceutics published in 1996, while the header pages
`were mistakenly taken out of the fourth edition of the textbook Modern
`Pharmaceutics published in 2002. Id. at 4. The corrected version of Rudnic
`that Petitioner requests be entered into the record, Exhibit 1042, contains the
`header pages and Chapter 10 from the third edition of the textbook Modern
`Pharmaceutics. Id. at 5. Petitioner contends that “the supplemental
`information does not change the substantive evidence provided in the
`original version of Rudnic; rather, it merely clarifies the edition of Modern
`Pharmaceutics from which the substance was obtained.” Id.
`In its Opposition, Patent Owners first contend that Petitioner’s request
`should be denied because the proposed supplemental information does not
`sufficiently address the issue of establishing Rudnic (Ex. 1010) as a prior art
`reference and that it is “important for the Board to ensure that supplemental
`information is not used to edit them after the fact.” Opp. 3–4. Patent Owner
`
`
`
`2
`
`
`
`IPR2018-00892
`Patent 9,326,945 B2
`
`also contends that it has been prejudiced by Petitioner’s mistake because
`“Patent Owners prepared their Preliminary Response without knowing what
`reference Petitioner meant to refer to.” Id. at 4. “Patent Owners cannot
`effectively contest the public availability or substance of a reference that
`Petitioner has not adequately identified.” Id. at 4–5. Finally, Patent Owner
`argues that Petitioner could have discovered its mistake sooner, but “waited
`until after institution to explain it away.” Id. at 5.
`Upon consideration of the documents and the parties’ arguments, and
`for the reasons stated below, Petitioner’s motion is granted.
`
`II. ANALYSIS
`As the moving party, Petitioner bears the burden of proving that it is
`entitled to the requested relief. 37 C.F.R. § 42.20(c). Here, because
`Petitioner seeks to submit supplemental information within one-month of
`institution, it must show that the information is “relevant to a claim for
`which the trial has been instituted.” 37 C.F.R. § 42.123(a). That said,
`however, section 123(a) “does not connote the PTAB must accept
`supplemental information so long as it is timely and relevant.” Redline
`Detection, LLC v. Star Envirotech, Inc., 811 F.3d 435, 445 (Fed. Cir. 2015)
`(citation omitted). In other words, satisfying the criteria of section 123(a)
`does not guarantee we will grant the motion and allow submission of the
`supplemental information.
`Instead, our guiding principle in evaluating a motion to submit
`supplemental information is “to ensure the efficient administration of the
`Office and the ability of the Office to complete IPR proceedings in a timely
`manner.” Redline Detection, 811 F.3d at 445 (citations and internal
`quotations omitted). “Requiring admission of supplemental information so
`
`
`
`3
`
`
`
`IPR2018-00892
`Patent 9,326,945 B2
`
`long as it was timely submitted and relevant to the IPR proceeding would cut
`against this mandate and alter the intended purpose of IPR proceedings.” Id.
`That purpose is to “secure the just, speedy, and inexpensive resolution of
`every proceeding.” 37 C.F.R. § 42.1(b). Consistent with that purpose, we
`consider whether submission of the supplemental information would change
`the grounds initially presented in the petition or otherwise unfairly change
`the evidence underlying those grounds. We also consider whether the patent
`owner would be prejudiced in having to respond to the supplemental
`information if permitted.
`Turning to the question of whether Petitioner’s supplemental
`information is “relevant to a claim for which the trial has been instituted,” 37
`C.F.R. § 42.123(a), we determine that the supplemental information
`Petitioner seeks to admit generally relates to the public availability of
`Rudnic, which is a basis for grounds of unpatentability in this proceeding,
`and is therefore relevant to the claims of the ’945 patent for which this trial
`was instituted. We recognize that permitting a petitioner to supplement the
`record could potentially change the evidence supporting the grounds
`originally presented in a petition in a manner that is not in accord with the
`statutory requirement that the petition identify “with particularity . . . the
`evidence that supports the grounds for the challenge to each claim,”
`including “affidavits or declarations of supporting evidence and opinions, if
`the petitioner relies on expert opinions.” 35 U.S.C. § 312(a)(3)(B). Here,
`however, the supplemental information does not change the grounds of
`unpatentability authorized in this proceeding, nor does it change the
`evidence initially presented in the Petition to support the grounds of
`unpatentability. In our Decision to Institute, we addressed Patent Owners’
`
`
`
`4
`
`
`
`IPR2018-00892
`Patent 9,326,945 B2
`
`arguments concerning the status of Rudnic as a printed publication. Paper
`24, 31–34. We noted that the factual dispute as to when Rudnic was
`published “may be resolved during trial.” Id. at 33. In that regard,
`Petitioner seeks to admit Ex. 1042 as evidence that Rudnic was published in
`the third edition of the textbook Modern Pharmaceutics published in 1996,
`thus allegedly confirming Rudnic as a printed publication. We see nothing
`wrong with Petitioner seeking to submit evidence on a dispositive issue at an
`early stage of trial so that Patent Owners may address the issue of whether
`Rundic is a prior art publication in its Patent Owner Response, should it
`wish to do so.
`We turn now to the question of whether granting the Motion is
`consistent with the efficient administration of this proceeding and the ability
`of the Board to ensure “the just, speedy, and inexpensive resolution of every
`proceeding.” 37 C.F.R. § 42.1(b). Here, we are not persuaded that the
`submission of the proposed supplemental information in this proceeding
`would limit our ability to satisfy that mandate. If we allow the supplemental
`information into the record at this juncture, Patent Owner will have
`sufficient time to address the supplemental information before filing the
`deadline of its Patent Owner Response, due January 15, 2019. Paper 25.
`Accordingly, we determine that admitting Exhibit 1042 as supplemental
`information will not inhibit the just, speedy, or efficient resolution of this
`proceeding, or our ability to complete it in a timely manner.
`Moreover, because Patent Owners will have sufficient time to address
`the supplemental information, we are not persuaded that Patent Owners will
`be unduly prejudiced. Furthermore, in this regard, we note that Patent
`
`
`
`5
`
`
`
`IPR2018-00892
`Patent 9,326,945 B2
`
`Owners already addressed the identical substance of Rudnic in its
`Preliminary Response. Paper 18, 16 and 23.
`
`III. ORDER
`For the reasons given:
`ORDERED that Petitioner’s motion to submit supplemental
`information under 37 C.F.R. § 42.123(a) is granted.
`FURTHER ORDERED that Exhibit 1042 shall be entered as evidence
`into the record.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`6
`
`
`
`IPR2018-00892
`Patent 9,326,945 B2
`
`For PETITIONER:
`
`Robert Florence
`Karen Carroll
`Micheal Binns
`Sharad Bijanki
`PARKER POE ADAMS & BERNSTEIN LLP
`robertflorence@parkerpoe.com
`karencarroll@parkerpoe.com
`michealbinns@parkerpoe.com
`sharadbijanki@parkerpoe.com
`
`For PATENT OWNER:
`
`Heather Petruzzi
`Timothy Cook
`Kevin Yurkerwich
`Michael Nelson
`WILMER CUTLER PICKERING HALE AND DORR LLP
`Heather.Petruzzi@wilmerhale.com
`Tim.Cook@wilmerhale.com
`Kevin.Yurkerwich@wilmerhale.com
`Michael.Nelson@wilmerhale.com
`
`
`
`7
`
`